Friday - April 10, 2026

Category Archives: Pharmaceuticals & Biotech

Global Obesity Pipeline Surges as 80+ Pharma Players Intensify Clinical Trials, Paving the Way for Next-Gen Weight Loss Therapies | DelveInsight

Obesity Pipelin Leading Obesity Companies include Zealand Pharma, Sciwind Biosciences, Genexine, Sirnaomics, Sparrow Pharmaceuticals, Shionogi, Regor Pharmaceuticals, Innovent Biologics, Pfizer, NodThera Limited, Boehringer Ingelheim, Fractyl Health, TransThera, Clearmind Medicine, PegBio, Biolingus, and others. DelveInsight’s “Obesity Pipeline Insight 2026” report provides … Continue reading →

Myelodysplastic Syndrome Pipeline Surges as 120+ Pharma Players Accelerate Clinical Innovation and Transform Treatment Landscape by 2034 | DelveInsight

Myelodysplastic Syndrome Pipeline Leading Myelodysplastic Syndrome Companies such as Syros Pharmaceuticals, Curis, Ryvu Therapeutics, Chia Tai Tianqing Pharmaceutical Group, Amgen, Sanofi, Forma Therapeutics, Agios Pharmaceuticals, AbbVie, Daiichi Sankyo Company, Geron Corporation, Astex Pharmaceuticals, Jazz Pharmaceuticals, Maxinovel Pty., Ltd., Mabwell (Shanghai) … Continue reading →

Hemophilia B Pipeline 2026 Report Highlights Next-Gen Gene Therapies, FDA Advances, and Clinical Momentum Across Novo Nordisk, Pfizer, Sanofi & Emerging Biotechs | DelveInsight

As per DelveInsight’s assessment, globally, Hemophilia B pipeline constitutes 15+ key companies continuously working towards developing 20+ Hemophilia B treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. As per DelveInsight’s assessment, … Continue reading →

Pneumococcal Infections Clinical Trial Pipeline Shows Potential with Active Contributions from 15+ Key Companies | DelveInsight

DelveInsight’s, “Pneumococcal infections Pipeline Insights 2026” Report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Pneumococcal infections pipeline landscape. It covers the Pneumococcal infections pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Fabry Disease Market Set for Robust Growth by 2034, Driven by Gene Therapy Breakthroughs and Expanding Pipeline from Sangamo, Sanofi, Amicus & Emerging Innovators | DelveInsight

Fabry Disease Market Fabry Disease Companies include Chiesi and Protalix Biotherapeutics, Sanofi Genzyme, Sangamo Therapeutics, Protalix Biotherapeutics, AVROBIO, Sanofi Genzyme, Sangamo Therapeutics, Freeline Therapeutics, 4D Molecular Therapeutics, Idorsia Pharmaceuticals, Greenovation Biotech GMBH, ICON plc, Chiesi Farmaceutici S.p.A., Amicus Therapeutics, Shire, … Continue reading →

Bladder Cancer Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Bladder Cancer Pipeline Insight 2026” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers the Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

NSCLC Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “NSCLC Pipeline Insight 2026” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in the NSCLC pipeline landscape. It covers the NSCLC pipeline drug profiles, including clinical and nonclinical stage products. It also covers the NSCLC pipeline … Continue reading →

Gastric Cancer Treatment Pipeline Shows Strong Momentum as 200+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Gastric Cancer Pipeline Insight 2026” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in the Gastric Cancer pipeline landscape. It covers the Gastric Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

MRSA Infections Clinical Trial Pipeline Gains Momentum: 25+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “MRSA Infections Pipeline Insights 2026” Report provides comprehensive insights about 25+ companies and 27+ pipeline drugs in MRSA Infections pipeline landscape. It covers the MRSA Infections pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Sepsis Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Sepsis Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Sepsis pipeline landscape. It covers the Sepsis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Sepsis pipeline … Continue reading →